Bruker Daltonics and Francisco Soria Melguizo S.A. Announce Exclusive Commercial Agreement for Distribution of the MALDI Biotyper in Spain HELSINKI, Finland--(BUSINESS WIRE)--May. 16, 2009--
At the 19th European Congress of Clinical Microbiology and
Infectious Disease (ECCMID), Bruker Daltonics announces an exclusive
distribution agreement for its MALDI
Biotyper with Francisco Soria Melguizo S.A. in Spain.
Francisco Soria Melguizo is one of the market leaders for clinical
microbiology in Spain, providing products for microbial identification
and antibiotics susceptibility testing. Bruker Daltonics is a global
leader in MALDI-TOF mass spectrometry and MALDI-TOF based identification
of microorganisms. The goal of the combination of Francisco Soria
Melguizo´s extensive distribution network and Bruker Daltonics´ service
capabilities is to provide comprehensive customer support. Francisco
Soria Melguizo will distribute the MALDI Biotyper to
laboratories in clinical microbiology and veterinary medicine in Spain.
Rafael Rumin, General Manager at Francisco Soria Melguizo, commented:
“The MALDI Biotyper is an amazing new molecular approach
for microbial identification. We are especially convinced of this system
due its broad success during the market introduction phase in Germany.
The Spanish microbiology market clearly recognizes the need for a new
technology. The MALDI Biotyper enables next generation
microbial identification for the 21st century.”
Dr. Wolfgang Pusch, Bruker Daltonics Vice President for the Clinical
Research and IVD Business, added: “After being very successful with the
market introduction of the MALDI Biotyper in Germany last
year, we now intend to promote it in additional major European markets.
With Francisco Soria Melguizo we have partnered with one of the major
providers for microbiology products in Spain with the aim to establish
the MALDI Biotyper as the new `gold standard´ in
microorganism identification in Spain.”
About the Bruker MALDI Biotyper
Bruker’s dedicated MALDI Biotyper solution enables
identification, taxonomical classification or dereplication of
microorganisms like bacteria, yeasts and fungi. Classification and
identification of microorganisms is achieved reliably and fast using
high-throughput MALDI-TOF mass spectrometry. Applications include
clinical routine microbial identification (in EU only - for research use
only elsewhere), environmental and pharmaceutical analysis, taxonomical
research, food and consumer product processing and quality control, as
well as in marine microbiology. Bruker’s robust MALDI Biotyper
method requires minimal sample preparation efforts and offers low cost
per sample.
ABOUT BRUKER CORPORATION (NASDAQ: BRKR)
Bruker is a leading provider of high-performance scientific instruments
and solutions for molecular and materials research, as well as for
industrial and applied analysis. For more information, please visit: www.bruker.com
ABOUT FRANCISCO SORIA MELGUIZO, S.A.
Francisco Soria Melguizo is a company present in the Spanish market for
50 years with focus in the preanalytical, diagnostic, veterinary,
research and industry areas. Francisco Soria Melguizo´s main business
activities are product and instruments manufacturer, consulting,
software development and long-term distribution agreements with global
leader companies. For more information, please visit: www.f-soria.es
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5966515&lang=en
Source: Bruker Daltonics
Karin Hoffmann
MALDI Biotyper Marketing, Bruker Daltonics
Tel:
+49-421-2205-2041
kho@bdal.de
|
Bruker Corporation
